Utilization of ketone bodies and glucose by established neural cell lines.
The rates of utilization of [3-14C]-acetoacetate, [3-14C]-3-hydroxybutyrate, and [6-14C]-glucose were measured in four established cell lines from neuroblastoma of rat (B103) and mouse (N4TG1) and from rat astrocytoma (RGC6) and mouse oligodendroglia (G2620). The rates of incorporation of acetoacetate into lipid were 3-5 times higher than glucose in all cell lines. The incorporation of 3-hydroxybutyrate was similar to that of glucose. Thin-layer chromatography of the total lipid extracts showed the same relative rates of use of these substrates for synthesis of various phospholipids and neutral lipids. The rates of incorporation into neutral lipids and phosphatidylcholine were essentially linear for 12 hr; however, that into phosphatidylethanolamine was markedly higher in the second 6 hr interval than in the first. In all cases, the greatest percentage of label (35-50%) appeared in the phosphatidylcholine fraction. The distribution of label from each of the three substrates among the various lipids was similar in the glial cells, but there were marked differences in distribution of the two ketone bodies in the neuroblastoma lines. These cells also synthesized lipids that migrated to the same area on the chromatogram as cholesterol esters and free fatty acids. In three of the four cell lines the rates of oxidation were highest for glucose, intermediate for acetoacetate, and lowest for 3-hydroxybutyrate. The ratios of the rate of incorporation to the rate of oxidation were higher for ketone bodies (3.32 for 3-hydroxybutyrate and 5.29 for acetoacetate) than for glucose (0.41). This indicates that in these cells ketone bodies are directed toward lipid synthesis rather than oxidation, and glucose is preferentially used as an energy source.
D020155:3-Hydroxybutyric Acid; D000090:Acetoacetates / Q000378:metabolism*; D000818:Animals; D001254:Astrocytoma / Q000378:metabolism; D001921:Brain / Q000166:cytology*; D002460:Cell Line; D002478:Cells, Cultured; D005947:Glucose / Q000378:metabolism*; D005950:Glucose Solution, Hypertonic / Q000378:metabolism*; D006885:Hydroxybutyrates / Q000378:metabolism*; D050356:Lipid Metabolism; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D009836:Oligodendroglia / Q000378:metabolism; D009837:Oligodendroglioma / Q000378:metabolism; D051381:Rats
D000090:Acetoacetates; D005950:Glucose Solution, Hypertonic; D006885:Hydroxybutyrates; C016635:acetoacetic acid; D005947:Glucose; D020155:3-Hydroxybutyric Acid